- Home
- SCOR vs LVTX Comparison
SCOR vs LVTX Comparison
Compare SCOR & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCOR
- LVTX
- Stock Information
- Founded
- SCOR 1999
- LVTX 2016
- Country
- SCOR United States
- LVTX Netherlands
- Employees
- SCOR N/A
- LVTX N/A
- Industry
- SCOR Business Services
- LVTX Biotechnology: Pharmaceutical Preparations
- Sector
- SCOR Consumer Discretionary
- LVTX Health Care
- Exchange
- SCOR Nasdaq
- LVTX Nasdaq
- Market Cap
- SCOR 34.6M
- LVTX 40.0M
- IPO Year
- SCOR 2007
- LVTX 2021
- Fundamental
- Price
- SCOR $6.66
- LVTX $1.57
- Analyst Decision
- SCOR Hold
- LVTX Hold
- Analyst Count
- SCOR 1
- LVTX 4
- Target Price
- SCOR $8.00
- LVTX $1.58
- AVG Volume (30 Days)
- SCOR 16.9K
- LVTX 204.5K
- Earning Date
- SCOR 08-05-2025
- LVTX 08-13-2025
- Dividend Yield
- SCOR N/A
- LVTX N/A
- EPS Growth
- SCOR N/A
- LVTX N/A
- EPS
- SCOR N/A
- LVTX N/A
- Revenue
- SCOR $358,513,000.00
- LVTX $4,990,000.00
- Revenue This Year
- SCOR $3.45
- LVTX N/A
- Revenue Next Year
- SCOR $2.59
- LVTX N/A
- P/E Ratio
- SCOR N/A
- LVTX N/A
- Revenue Growth
- SCOR N/A
- LVTX N/A
- 52 Week Low
- SCOR $4.39
- LVTX $0.85
- 52 Week High
- SCOR $8.99
- LVTX $2.09
- Technical
- Relative Strength Index (RSI)
- SCOR 55.64
- LVTX 62.69
- Support Level
- SCOR $6.37
- LVTX $1.50
- Resistance Level
- SCOR $6.97
- LVTX $1.57
- Average True Range (ATR)
- SCOR 0.40
- LVTX 0.03
- MACD
- SCOR -0.02
- LVTX -0.00
- Stochastic Oscillator
- SCOR 59.34
- LVTX 93.33
About SCOR comScore Inc.
comScore Inc is a United States-based information and analytics company that measures advertising, content, and the consumer audiences of each across media platforms. The platforms it measures include televisions, mobile devices, computers, tablets, CTV devices, and movie theaters. The company generates almost all its revenue from the United States, followed by Europe, Latin America, Canada, and other regions. It provides solutions for the automotive, digital media, financial services, pharmaceutical, retail, technology, travel, and other industries.
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.